@FierceMedDev: Natera hauls in $54.6M for prenatal Dx. News | Follow @FierceMedDev
@MarkHFierce: An MRI scan to measure brain atrophy could predict MS, a new University at Buffalo study has determined. More | Follow @MarkHFierce
@DamianFierce: Join us for a trip through why a repeal of the medical device tax is unlikely to happen any time soon. Editor's corner | Follow @DamianFierce
> Sales at Wright Medical ($WMGI) declined in its fiscal 2013 first quarter, impacted in part by price decreases in Japan but offset to a degree by a growing global foot and ankle business. Release
> Navidea Biopharmaceuticals ($NAVB) has launched its diagnostic aid Lymphoseek in the U.S. More
> Medical device entrepreneurs say that FDA policies are killing innovation. Story
> GI Dynamics ($GID) appointed Amylin Pharmaceuticals veteran David Maggs as its new chief medical officer. News
> Cleveland Clinic spinout Rindex Medical is developing a tool that would help predict which patients will face atrial fibrillation after cardiac surgery, which would flag them for preemptive treatment to prevent problems. Story
> Haemonetics ($HAE) raked in $249.9 million in revenue last quarter, a 34% increase, but net income dropped 29% to $12.6 million. Results
> Breast implants can delay doctors' ability to diagnose breast cancer, according to a study. Article
> Sanuwave Health has named Pfizer ($PFE) veteran Daniel Jorgensen as its new CMO. Item
Biotech News
@FierceBiotech: ICYMI, check out newest Industry Voices: Time to Take Fecal Transplantation Seriously. Feature | Follow @FierceBiotech
@JohnCFierce: Seems likely to me that Merck is going to cut open R&D and do some major surgery. Perlmutter is two weeks on the job. | Follow @JohnCFierce
@RyanMFierce: Just talked to Semantelli about IMS Health deal: IMS Health acquires social media analytics startup Semantelli. Report | Follow @RyanMFierce
> Merck spotlights new deals, R&D review as demands to rebuild pipeline grow. Story
> VCs provide $40M to finance Celator's pivotal PhIII AML study. News
> FDA steamrolls over panel vote, spurns Titan's addiction drug Probuphine. Article
Pharma News
@FiercePharma: Scary-odd news from Bloomberg: Amgen blood drugs may help victims survive nuclear attack. Story | Follow @FiercePharma
@EricPFierce: FDA tests the waters on Plan B, approves it for girls 15 and older, off the shelf but requires proof of age. Report | Follow @EricPFierce
> Novo's exceptional first quarter still disappoints. Report
> Amgen blood drugs may help humans survive nuclear attack, FDA says. Article
> Lagging Januvia weighs on Merck's none-too-pretty first quarter. More
Biomarkers News
> Dozens of new biomarkers gauge ovarian cancer survival prospects. Report
> Investigators profile a lethal tumor cell that could spur metastasis. Article
> Verastem gears up for companion Dx mesothelioma treatment trial. More
> Brain atrophy could predict MS, study finds. Story
> Key biomarker measure + CT scan predict melanoma survival odds. Item
Drug Delivery News
@MichaelGFierce: Merck, Celgene cancer nanomeds combined for better delivery. Report | Follow @MichaelGFierce
> Researchers open window through blood-brain barrier. Story
> ClearPoint MRI-guided device sheds light on drug delivery to the brain. Editor's corner
> 'Spider' protein can deliver stable vaccines in high concentration. More
> Insuline's InsuPatch delivery device suffers FDA setback. Item